Country: United States
Language: English
Source: NLM (National Library of Medicine)
Lithium Citrate (UNII: 5Z6E9K79YV) (Lithium Cation - UNII:8H8Z5UER66)
Precision Dose Inc.
Lithium Citrate
Lithium Cation 8 meq in 5 mL
ORAL
PRESCRIPTION DRUG
Lithium is a mood-stabilizing agent indicated for the treatment of manic episodes and as maintenance treatment for Bipolar I Disorder. Lithium is contraindicated in patients with known hypersensitivity to any inactive ingredient in the lithium carbonate tablet or capsule or lithium citrate products [see Adverse Reactions (6), Description (11)] . Risk Summary Lithium may cause harm when administered to a pregnant woman. Early voluntary reports to international birth registries suggested an increase in cardiovascular malformations, especially for Ebstein's anomaly, with first trimester use of lithium. Subsequent case-control and cohort studies indicate that the increased risk for cardiac malformations is likely to be small; however, the data are insufficient to establish a drug-associated risk. There are concerns for maternal and/or neonatal lithium toxicity during late pregnancy and the postpartum period [see Clinical Considerations] . Published animal developmental and toxicity studies in mice and rats report
Lithium Oral Solution USP, 8 mEq per 5 mL. Lithium Oral Solution USP is supplied as a clear nearly colorless solution. NDC 68094-757-62 5 mL per unit dose cup Thirty (30) cups per shipper Store and Dispense Store at 20°C to 25°C (68°F to 77°F); excursions permitted to 15°C to 30°C (59°F to 86°F). [See USP Controlled Room Temperature.] Dispense in a tight, child-resistant container as defined in the USP/NF.
New Drug Application
Precision Dose Inc. ---------- This Medication Guide is approved by the U.S. Food and Drug Administration. MEDICATION GUIDE Lithium (LITH-ee-əm) Oral Solution USP Lithium Carbonate Tablets USP Lithium Carbonate Capsules USP Rx only What is the most important information I should know about Lithium and Lithium Carbonate? Lithium and Lithium Carbonate can cause serious side effects, including too much lithium in your blood (lithium toxicity). Lithium toxicity can happen even if the lithium level in your blood is close to the right level for you. Your healthcare provider will need to monitor your blood levels of lithium to find the best dose for you. Take your Lithium or Lithium Carbonate exactly as your healthcare provider tells you to take it. Stop taking Lithium and Lithium Carbonate and call your healthcare provider right away if you have any symptoms of lithium toxicity including: • abnormal heartbeat • diarrhea • weak muscles • clumsiness • vomiting • drowsiness • blurred vision • ear ringing What is Lithium and Lithium Carbonate? Lithium and Lithium Carbonate are prescription medicines called mood-stabilizing agents used to treat manic episodes and as a long term treatment of bipolar disorder. Lithium and Lithium Carbonate are not for people with severe kidney problems. It is not known if Lithium and Lithium Carbonate are safe and effective in children. Who should not take Lithium or Lithium Carbonate? Do not take Lithium or Lithium Carbonate if you are allergic to Lithium or any of the ingredients in Lithium Carbonate or Lithium Citrate. See the end of this Medication Guide for a complete list of ingredients in Lithium and Lithium Carbonate. What should I tell my healthcare provider before taking Lithium or Lithium Carbonate? Before taking Lithium or Lithium Carbonate, tell your healthcare provider if you: • have kidney problems • have heart problems • have thyroid problems • are pregnant or plan to become pregnant. Lithium and Lithium Carbonate may harm your unborn baby. • are bre Read the complete document
LITHIUM- LITHIUM SOLUTION PRECISION DOSE INC. ---------- HIGHLIGHTS OF PRESCRIBING INFORMATION THESE HIGHLIGHTS DO NOT INCLUDE ALL THE INFORMATION NEEDED TO USE LITHIUM SAFELY AND EFFECTIVELY. SEE FULL PRESCRIBING INFORMATION FOR LITHIUM. LITHIUM ORAL SOLUTION, FOR ORAL USE INITIAL U.S. APPROVAL: 1970 WARNING: LITHIUM TOXICITY _SEE FULL PRESCRIBING INFORMATION FOR COMPLETE BOXED WARNING_ LITHIUM TOXICITY IS CLOSELY RELATED TO SERUM LITHIUM CONCENTRATIONS, AND CAN OCCUR AT DOSES CLOSE TO THERAPEUTIC CONCENTRATIONS. FACILITIES FOR PROMPT AND ACCURATE SERUM LITHIUM DETERMINATIONS SHOULD BE AVAILABLE BEFORE INITIATING THERAPY (2.6, 5.1). INDICATIONS AND USAGE Lithium is a mood stabilizing agent indicated for the treatment of manic episodes and as maintenance treatment for Bipolar I Disorder. (1) DOSAGE AND ADMINISTRATION Recommended starting dosage (2.2): Tablets or Capsules: 300 mg, three times daily or Oral Solution: 5 mL (8mEq lithium) three times daily Obtain serum lithium concentration assay after 4 days, drawn 12 hours after the last oral dose and regularly until patient is stabilized. Manic Episode: Titrate to serum lithium concentrations 0.8 to 1.2 mEq/L, which may be achieved with (2.3): Tablets or Capsules: 600 mg, two to three times daily or Oral Solution: 10 mL (16 mEq lithium), two to three times daily Maintenance Treatment for Bipolar I Disorder: Titrate to serum lithium concentrations 0.8 to 1 mEq/L, which may be achieved with (2.4): Tablets or Capsules: 300 mg to 600 mg, two to three times daily or Oral Solution: 5 mL to 10 mL (8-16 mEq lithium), two to three times daily Pre-treatment Screening: Evaluate renal function, vital signs, electrolytes, thyroid function, concurrent medications, and pregnancy status. (2.1) Adjust daily dosage based on serum lithium concentration and clinical response. (2.6) Mild to Moderate Renal Impairment (CLer 30 to 89 mL/min): Start with low dose, titrate slowly with frequent monitoring. (2.8) Severe Renal Impairment (CLer<30mL/min): Avoid use of lithium.(2.8) DOSAGE FORM Read the complete document